Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Pacira Pharma (PCRX) Reports In-Line Q1 EPS
May 3, 2018 8:06 AM EDTPacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $74.6 million versus the consensus estimate of $73.69 million.
Pacira reiterated its full year 2018 financial guidanceFor earnings history and earnings-related data on Pacira Pharma (PCRX) click here.
... More


